352 related articles for article (PubMed ID: 21804542)
1. Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11.
Sasaki M; Kawahara K; Nishio M; Mimori K; Kogo R; Hamada K; Itoh B; Wang J; Komatsu Y; Yang YR; Hikasa H; Horie Y; Yamashita T; Kamijo T; Zhang Y; Zhu Y; Prives C; Nakano T; Mak TW; Sasaki T; Maehama T; Mori M; Suzuki A
Nat Med; 2011 Jul; 17(8):944-51. PubMed ID: 21804542
[TBL] [Abstract][Full Text] [Related]
2. PICT1 regulates TP53 via RPL11 and is involved in gastric cancer progression.
Uchi R; Kogo R; Kawahara K; Sudo T; Yokobori T; Eguchi H; Sugimachi K; Maehama T; Mori M; Suzuki A; Komune S; Mimori K
Br J Cancer; 2013 Oct; 109(8):2199-206. PubMed ID: 24045667
[TBL] [Abstract][Full Text] [Related]
3. The role of PICT1 in RPL11/Mdm2/p53 pathway-regulated inhibition of cell growth induced by topoisomerase IIα inhibitor against cervical cancer cell line.
Rao Z; Shen J; Wang J; Zhang Z; Zhou J; Zhu J; Chen J; Chen W; Wang H
Biochem Pharmacol; 2022 Jul; 201():115098. PubMed ID: 35605655
[TBL] [Abstract][Full Text] [Related]
4. A new PICTure of nucleolar stress.
Suzuki A; Kogo R; Kawahara K; Sasaki M; Nishio M; Maehama T; Sasaki T; Mimori K; Mori M
Cancer Sci; 2012 Apr; 103(4):632-7. PubMed ID: 22320853
[TBL] [Abstract][Full Text] [Related]
5. PICT-1 is a key nucleolar sensor in DNA damage response signaling that regulates apoptosis through the RPL11-MDM2-p53 pathway.
Chen H; Han L; Tsai H; Wang Z; Wu Y; Duo Y; Cao W; Chen L; Tan Z; Xu N; Huang X; Zhuang J; Huang L
Oncotarget; 2016 Dec; 7(50):83241-83257. PubMed ID: 27829214
[TBL] [Abstract][Full Text] [Related]
6. PICT1 is critical for regulating the Rps27a-Mdm2-p53 pathway by microtubule polymerization inhibitor against cervical cancer.
Wang H; Zhao J; Yang J; Wan S; Fu Y; Wang X; Zhou T; Zhang Z; Shen J
Biochim Biophys Acta Mol Cell Res; 2021 Sep; 1868(10):119084. PubMed ID: 34166715
[TBL] [Abstract][Full Text] [Related]
7. GRWD1 negatively regulates p53 via the RPL11-MDM2 pathway and promotes tumorigenesis.
Kayama K; Watanabe S; Takafuji T; Tsuji T; Hironaka K; Matsumoto M; Nakayama KI; Enari M; Kohno T; Shiraishi K; Kiyono T; Yoshida K; Sugimoto N; Fujita M
EMBO Rep; 2017 Jan; 18(1):123-137. PubMed ID: 27856536
[TBL] [Abstract][Full Text] [Related]
8. Identification of a small-molecule RPL11 mimetic that inhibits tumor growth by targeting MDM2-p53 pathway.
Wang B; Gao J; Zhao Z; Zhong X; Cui H; Hou H; Zhang Y; Zheng J; Di J; Liu Y
Mol Med; 2022 Sep; 28(1):109. PubMed ID: 36071402
[TBL] [Abstract][Full Text] [Related]
9. GRWD1, a new player among oncogenesis-related ribosomal/nucleolar proteins.
Takafuji T; Kayama K; Sugimoto N; Fujita M
Cell Cycle; 2017 Aug; 16(15):1397-1403. PubMed ID: 28722511
[TBL] [Abstract][Full Text] [Related]
10. mTOR inhibitors blunt the p53 response to nucleolar stress by regulating RPL11 and MDM2 levels.
Goudarzi KM; Nistér M; Lindström MS
Cancer Biol Ther; 2014; 15(11):1499-514. PubMed ID: 25482947
[TBL] [Abstract][Full Text] [Related]
11. Acrolein preferentially damages nucleolus eliciting ribosomal stress and apoptosis in human cancer cells.
Wang HT; Chen TY; Weng CW; Yang CH; Tang MS
Oncotarget; 2016 Dec; 7(49):80450-80464. PubMed ID: 27741518
[TBL] [Abstract][Full Text] [Related]
12. Nucleolar protein GLTSCR2 stabilizes p53 in response to ribosomal stresses.
Lee S; Kim JY; Kim YJ; Seok KO; Kim JH; Chang YJ; Kang HY; Park JH
Cell Death Differ; 2012 Oct; 19(10):1613-22. PubMed ID: 22522597
[TBL] [Abstract][Full Text] [Related]
13. Non-genotoxic activation of p53 through the RPL11-dependent ribosomal stress pathway.
Morgado-Palacin L; Llanos S; Urbano-Cuadrado M; Blanco-Aparicio C; Megias D; Pastor J; Serrano M
Carcinogenesis; 2014 Dec; 35(12):2822-30. PubMed ID: 25344835
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the MDM2-p53 pathway by the nucleolar protein CSIG in response to nucleolar stress.
Xie N; Ma L; Zhu F; Zhao W; Tian F; Yuan F; Fu J; Huang D; Lv C; Tong T
Sci Rep; 2016 Nov; 6():36171. PubMed ID: 27811966
[TBL] [Abstract][Full Text] [Related]
15. Ribosomal protein L4 is a novel regulator of the MDM2-p53 loop.
He X; Li Y; Dai MS; Sun XX
Oncotarget; 2016 Mar; 7(13):16217-26. PubMed ID: 26908445
[TBL] [Abstract][Full Text] [Related]
16. Ribosomal protein RPL11 haploinsufficiency causes anemia in mice via activation of the RP-MDM2-p53 pathway.
Franklin DA; Liu S; Jin A; Cui P; Guo Z; Arend KC; Moorman NJ; He S; Wang GG; Wan YY; Zhang Y
J Biol Chem; 2023 Jan; 299(1):102739. PubMed ID: 36435197
[TBL] [Abstract][Full Text] [Related]
17. Ribosomal proteins L11 and L5 activate TAp73 by overcoming MDM2 inhibition.
Zhou X; Hao Q; Zhang Q; Liao JM; Ke JW; Liao P; Cao B; Lu H
Cell Death Differ; 2015 May; 22(5):755-66. PubMed ID: 25301064
[TBL] [Abstract][Full Text] [Related]
18. Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis.
Liu S; Tackmann NR; Yang J; Zhang Y
Oncogene; 2017 Mar; 36(10):1374-1383. PubMed ID: 27617574
[TBL] [Abstract][Full Text] [Related]
19. RPL23 Links Oncogenic RAS Signaling to p53-Mediated Tumor Suppression.
Meng X; Tackmann NR; Liu S; Yang J; Dong J; Wu C; Cox AD; Zhang Y
Cancer Res; 2016 Sep; 76(17):5030-9. PubMed ID: 27402081
[TBL] [Abstract][Full Text] [Related]
20. Nucleolar Stress Response via Ribosomal Protein L11 Regulates Topoisomerase Inhibitor Sensitivity of P53-Intact Cancers.
Ishihara Y; Nakamura K; Nakagawa S; Okamoto Y; Yamamoto M; Furukawa T; Kawahara K
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]